Surrogate viruses for use in disinfectant efficacy tests to justify claims against Monkeypox
Published
Related content
- Coronavirus (COVID-19): Information on medicines and medical devicesThe TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page
- Using 'natural' claims when advertising to the publicReasons for releasing guidance and how it was developed
- Zafe Zone fined almost $40,000 for alleged advertising breaches for disinfectant products in relation to COVID-19The TGA has issued three infringement notices totalling $39,960 to Melbourne-based company Italian Princess Coffee Brands Pty Ltd (trading as Zafe Zone)